NEUP (Neuphoria Therapeutics) Sale Of Property, Plant, Equipment : $0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics Sale Of Property, Plant, Equipment?

Neuphoria Therapeutics's sale of property, plant, equipment for the three months ended in Dec. 2024 was $0.00 Mil. It means Neuphoria Therapeutics gained $0.00 Mil from selling property, plant, and equipment. Neuphoria Therapeutics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2024 ), Neuphoria Therapeutics gained the same money from selling property, plant, and equipment in Dec. 2024 ($0.00 Mil).

Neuphoria Therapeutics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Neuphoria Therapeutics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuphoria Therapeutics Sale Of Property, Plant, Equipment Chart

Neuphoria Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

0.18

0.03

0.12

Neuphoria Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Neuphoria Therapeutics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Neuphoria Therapeutics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Neuphoria Therapeutics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuphoria Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Summit Dr, Burlington, MA, USA, 01803

Website

https://www.bionomics.com.au

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.